1832 Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-157	Closed	-$21K	–	889
2021 Q2	$21K	Sell	157 -3,255	-95%	-$428K	﹤0.01%	663
2021 Q1	$446K	Sell	3,412 -105	-3%	-$15.7K	﹤0.01%	486
2020 Q4	$508K	Sell	3,517 -661	-16%	-$84.7K	﹤0.01%	534
2020 Q3	$470K	Buy	4,178 +1,535	+58%	+$172K	﹤0.01%	511
2020 Q2	$294K	Buy	+2,643	New	+$260K	﹤0.01%	515
2020 Q1	–	Sell	-5,211	Closed	-$497K	–	770
2019 Q4	$497K	Buy	5,211 +4,148	+390%	+$359K	﹤0.01%	472
2019 Q3	$81K	Hold	1,063	–	–	﹤0.01%	551
2019 Q2	$93K	Hold	1,063	–	–	﹤0.01%	560
2019 Q1	$93K	Hold	1,063	–	–	﹤0.01%	489
2018 Q4	$77K	Hold	1,063	–	–	﹤0.01%	473
2018 Q3	$102K	Sell	1,063 -17,746	-94%	-$1.72M	﹤0.01%	525
2018 Q2	$1.79M	Sell	18,809 -1,039	-5%	-$95.5K	0.01%	386
2018 Q1	$1.75M	Sell	19,848 -1,568	-7%	-$143K	0.01%	378
2017 Q4	$1.81M	Buy	21,416 +6,160	+40%	+$516K	0.01%	379
2017 Q3	$1.28M	Hold	15,256	–	–	﹤0.01%	406
2017 Q2	$1.18M	Sell	15,256 -39,489	-72%	-$2.8M	0.01%	422
2017 Q1	$3.8M	Buy	+54,745	New	+$3.68M	0.01%	355